Explore our premium bio-active ingredients, custom-tailored to support the expanding Unani, Ayurvedic, and modern pharmaceutical industries in Bangladesh.
Bangladesh's pharmaceutical sector is undergoing an unprecedented structural transition. Meeting 98% of domestic demands and exporting globally, the local industry has historically relied on synthetic Active Pharmaceutical Ingredients (APIs). However, as Bangladesh prepares for LDC graduation by 2026, the regulatory and economic incentives are shifting dramatically toward natural raw materials, bio-active botanical APIs, and standardized extracts.
A booming sector driving this transition is the Ayurvedic, Unani, and Herbal medicines system. Historically relying on raw botanical powders, local companies such as Square Pharmaceuticals, Hamdard Bangladesh, and Acme Laboratories are rapidly moving to standardized phytochemical compounds to achieve predictable therapeutic efficacy and comply with international regulations.
Furthermore, Bangladesh's national API Industrial Park in Munshiganj signifies the government's push for raw material localization. By leveraging high-purity standardized plant extracts, local formulators can enhance therapeutic values, lower toxicological profiles, and tap into global export markets seeking clean-label pharmaceutical products.
Standardized botanical matrices manufactured using clean-room technology for pharmaceutical stability and biological availability.
Standardized plant extracts are bio-chemical structures highly sensitive to humidity, temperature, and microbiological contamination. In Bangladesh's tropical climate, sourcing low-grade raw materials often leads to stability failures in pharmaceutical batches. This is where Chengdu Chenlv Herb's Industry 4.0 processing paradigm provides a technological edge:
With Bangladesh's rising foreign exchange regulations and shipping considerations, partnering directly with a robust, high-volume Chinese manufacturer guarantees stable pricing, rapid shipping lanes, and continuous contract manufacturing support.
Discover how our manufacturing capabilities translate directly to your product quality and regulatory compliance.
Advanced R&D team generating innovative botanical formulations and customizable concentrations that elevate and differentiate your brand in competitive markets.
High-efficiency extraction techniques paired with sustainable, eco-friendly processing and packaging systems designed to align with modern environmental values.
Comprehensive end-to-end extraction and supply chain solutions tailored for diverse industries including functional foods, pharmaceuticals, and cosmetic applications.
Optimized logistics networks and rapid production turnaround periods ensures we meet strict time schedules and emergency pharmaceutical runs.
Dedicated quality management professionals supporting clients through registration, document verification (DMF/COA), and technical audits.
Over a decade of specialized plant extraction and global B2B supply expertise, guaranteeing consistent purity, assay precision, and raw material safety.
Chengdu Chenlv Herb provides end-to-end contract manufacturing and formulation customization, ensuring seamless integration into your production line.
Aligning product requirements, parameters, and assays.
Transparent wholesale cost calculations based on raw materials.
Legally binding agreements defining standard batch sizes and delivery.
Laboratory trial batch and formulation synthesis for review.
Scaling standard batch output in GMP cleanrooms after sign-off.
Issuing Certificate of Analysis (COA) for purity and microbiological safety.
Integrating efficient air/ocean freight pathways directly to Chittagong or Dhaka.
Our standardized plant extracts satisfy the strict quality requirements across multiple demanding industries.
Driven by the concept of "homology of medicine and food" and modern health needs, plant extracts have gradually become the core raw materials for the development of health care products due to their natural, green and safe characteristics.
From herbal formulas recorded in ancient books to modern innovative drugs, plant extracts occupy the prominent position in the pharmaceutical industry due to their natural active ingredients and unique pharmacological effects.
With consumers' pursuit of natural, safe, and sustainable skincare concepts, plant extracts have become a new favorite in the cosmetics industry due to their mildness, versatility, and biocompatibility, bringing new solutions for skin care.
Plant extracts have shown great potential in improving animal health, enhancing production performance and optimizing culture benefits, and are gradually becoming a research hotspot and new favorite in the field of animal nutrition.
Understanding the critical difference in therapeutic efficacy, contamination control, and shelf stability for Bangladeshi manufacturing environments.
| Quality Parameters | Traditional Raw Herbal Powder | Modern Industry 4.0 Standardized Extracts | Value to Bangladeshi Manufacturers |
|---|---|---|---|
| Therapeutic Assay Standard | Variable active compound concentration based on seasonal harvesting factors. | Guaranteed standard percentages of bio-actives (e.g. Ginsenosides, Glycyrrhizin) verified by HPLC. | Ensures reproducible pharmacological effects across batch runs. |
| Microbiological Bio-burden | High risk of mold, yeast, and coliform contamination in tropical climates. | Sterilized clean-room processing guaranteeing <1000 CFU/g limits. | Ensures products pass stringent DGDA microbiological tests. |
| Heavy Metal Limits | High levels of lead, arsenic, and mercury absorbed from topsoil. | Controlled membrane filtration limits heavy metal contents to <10ppm. | Complies with global export standards, easing regulatory approval. |
| Shelf-Life Stability | Prone to oxidation and humidity damage in 12 months. | Vacuum packaging with moisture-controlled dessicants for 24+ months. | Decreases warehousing losses during extended tropical storage. |
Our extraction lines and processes conform with international protocols including ISO9001, ISO22000, HALAL, KOSHER and FDA, ensuring smooth clearance through the Chittagong custom house.
Technical guidance and logistical answers for buying plant extracts in Bangladesh.
Importers must present standard documents to the Directorate General of Drug Administration (DGDA) or the Bangladesh Standards and Testing Institution (BSTI), including a Certificate of Analysis (COA), Certificate of Origin, GMP certification of the manufacturer, and a Material Safety Data Sheet (MSDS). Chengdu Chenlv Herb provides complete registration dossiers to expedite import approvals.
Yes. Traditional Unani and Ayurvedic practitioners rely on botanical active molecules. Sourcing standardized extracts guarantees that therapeutic items like natural syrups, tablets, and capsules maintain a consistent dose of active phytochemicals per batch, ensuring predictable consumer results.
Every batch of raw extracts undergoes Gas Chromatography-Mass Spectrometry (GC-MS) and High-Performance Liquid Chromatography (HPLC) testing. We enforce strict residual solvent thresholds to comply with EU, US FDA, and Bangladesh pharmacopoeia regulations.
Standard custom orders take 2 to 3 weeks to process. Shipping from China to Chittagong seaport typically takes 14 to 20 days. Air shipments to Hazrat Shahjalal International Airport in Dhaka arrive within 3 to 7 days, providing quick replenishment options for urgent production schedules.
Yes, our plant extraction processes and facility lines are HALAL certified, meeting the dietary and religious requirements for food, beverage, and pharma applications in Bangladesh.
Standardized botanical matrices manufactured in ISO-certified cleanrooms, optimized for tropical storage stability.
Stay informed with our insights on raw material price trends and global trade conferences.
Recently, the market price of Citrus aurantium raw materials in China has been on the rise, drawing significant attention from the industry. As the new production season comes to an end and new supplies enter the market, price fluctuations have become a focal point due to supply and demand dynamics and cost considerations.
As a 'calling card' for leading China's pharmaceutical industry onto the global stage, the 23rd China Pharmaceutical Raw Materials Exhibition (CPHI China 2025) will join hands with the 18th China Pharmaceutical Machinery.
Discover our latest solutions in industrial biotechnology, custom formulation techniques, and meet our principal research team to build resilient supply networks.